| Literature DB >> 30621824 |
Rachel Shirazi1,2, Paolo Pozzi2,3, Marina Wax1, Itay Bar-Or1, Efrat Asulin1, Yaniv Lustig1, Ella Mendelson1,4, Ziv Ben-Ari5,6, Eli Schwartz6,7, Orna Mor1,4.
Abstract
IntroductionThe zoonotic hepatitis E virus (HEV) genotype 3 (HEV-G3) has become a common cause of acute and chronic hepatitis among humans worldwide. In Israel, while HEV-3 sequences have previously been detected in sewage, only the non-zoonotic HEV-G1 genotype has been found in samples from human patients.AimIn this pilot study, we aimed to assess the status of HEV in a sample of the swine population and among swine farm workers in Israel.MethodsPig blood (n = 141) and faecal samples (n = 39), pig farm sewage samples (n = 8) and blood from farm workers (n = 24) were collected between February 2016 and October 2017. Anti-HEV IgG was detected using the Wantai assay. HEV RNA was analysed with the RealStar HEV kit. HEV open reading frame 1 fragments amplified from representative HEV RNA-positive samples were used for phylogenetic analysis.ResultsOverall prevalence of HEV antibodies in pigs was 75.9% (107/141). HEV RNA was detected in plasma (2.1%, 3/141), faecal (22.8%, 18/79) and pig sewage (4/8) samples. Pig and sewage-derived viral sequences clustered with previously identified human sewage HEV-G3 sequences. Most pig farms workers (23 of 24) were HEV-seropositive; none was viraemic or reported previous clinical signs.ConclusionsThis study showed that domestic pigs in Israel are infected with HEV-G3. The high HEV seropositivity of the farm workers together with the previous identification of this virus in human sewage suggests circulation to humans. The clinical impact of these findings on public health should be further explored.Entities:
Keywords: HEV RNA; HEV-G3; Hepatitis E; Seroprevalence; pigs; sewage
Mesh:
Substances:
Year: 2018 PMID: 30621824 PMCID: PMC6290533 DOI: 10.2807/1560-7917.ES.2018.23.49.1800067
Source DB: PubMed Journal: Euro Surveill ISSN: 1025-496X
Figure 1Number and prevalence of pigs with IgG antibodies against hepatitis E virus, by age group, Israel, February 2016–October 2017 (n = 141)
Anti-hepatitis E virus IgG and hepatitis E virus RNA-positive samples in blood, faeces and sewage from pigs in northern and southern breeding farms, Israel, February 2016–October 2017
| Region of breeding farms | Age (months) | Blood (n = 141) | Faeces (n = 79) | Sewage (n = 8) | ||||
|---|---|---|---|---|---|---|---|---|
| All samples tested | IgG-positive samples | RNA-positive samples | All samples tested | RNA-positive samples | All samples tested | RNA-positive samples | ||
| North Israel | 1.5 | 20 | 17 | 0 | 15 | 0 | 6 | 2 |
| 2.5 | 21 | 7 | 2 | 16 | 9 | |||
| 3.5 | 14 | 6 | 1 | 24 | 6 | |||
| 4.5 | 24 | 3 | ||||||
| 6 | 30 | 28 | 0 | NA | NA | |||
| >12 | 18 | 18 | 0 | NA | NA | |||
| South Israel | 2.5 | 10 | 2 | 0 | NA | NA | 2 | 2 |
| 6 | 28 | 28 | 0 | NA | NA | |||
NA: not available.
Figure 2Phylogenetic analysis of the Israeli isolates of hepatitis E virus, Israel, February 2016–October 2017 (n = 8)